Lanza

Telegraph - November 20, 2009 12:13 AM

The first human trials of a stem cell therapy for an eye disease that causes blindness in young people could start next year. The pioneering treatment could help people losing their sight due to Stargardt, a currently untreatable disease that is one of ...

Times Online - November 19, 2009 4:43 PM

Patients with a rare and incurable eye disease that causes blindness early in adulthood are expected to become the first people to benefit from an embryonic stem-cell therapy. Clinical trials of the treatment for Stargardts disease are expected to begin ...

ABC News - November 19, 2009 11:18 AM

WASHINGTON (Reuters) - Advanced Cell Technology, a small Massachusetts-based biotechnology company, said on Thursday it has asked for approval to test human embryonic stem cells in treating a rare cause of blindness. The company said it filed an IND, an ...

Times Online - November 19, 2009 9:57 AM

Patients with a rare and incurable eye disease that causes blindness early in adulthood are poised to become the first people to benefit from an embryonic stem cell therapy. Clinical trials of the treatment for Stargardts disease are expected to begin ...

Forbes.com - November 19, 2009 9:00 AM

WASHINGTON, Nov 19 (Reuters) - The company said it filed an IND, an investigational new drug application, with the U.S. Food and Drug Administration to use the stem cells to treat patients with Stargardt's macular dystrophy. If approved, it would be the ...